The feasibility of circulating tumor DNA analysis as a marker of recurrence in triple-negative breast cancer.
Okazaki S, Sasaki T, Yasuda S, Abe M, Yoshida N, Yoshida R, Ishibashi K, Minami Y, Okumura S, Chiba S, Takei H, Hayashi R, Nagato T, Kobayashi H, Sugitani A, Ono Y, Mizukami Y, Kitada M, Ohsaki Y.
Okazaki S, et al. Among authors: kitada m.
Oncol Lett. 2021 May;21(5):420. doi: 10.3892/ol.2021.12681. Epub 2021 Mar 28.
Oncol Lett. 2021.
PMID: 33841581
Free PMC article.